Marijuana Stocks Shunned by US Institutional Investors – For Now

Marijuana Stocks Shunned By Us Institutional Investors – For Now

Share Tweet Share PinWith all the revenue flowing in support of the burgeoning cannabis market, one would think that US stockbrokers and big-time investors are plunging right in. However, a cannabis gold rush in which brokerage firms are busily filling orders for marijuana stocks isn’t a reality – not in the US, anyway. “It’s really a tale of two markets,” said Hadley Ford, CEO and director of New York-based iAnthus Capital, which through its wholly-owned subsidiary provides investors diversified exposure to licensed cannabis cultivators, processors and dispensaries throughout the US. “There’s Canada and the US, and Canada is probably two to three years ahead of the US market.” Ford is a healthcare and technology veteran who has been an operating executive, entrepreneur and an investment banker, including stints with First Boston, Bank of America and Goldman Sachs. Now he’s on board with bringing more capital into the cannabis market. In Canada, where medical cannabis is legal...

See Article on HERE